Attached files
| file | filename |
|---|---|
| 10-Q - NANOVIRICIDES, INC. 10-Q 12-31-2010 - NANOVIRICIDES, INC. | form10-q.htm |
| EX-31.1 - EXHIBIT 31.1 - NANOVIRICIDES, INC. | ex31_1.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q (the “Report”) of NanoViricides, Inc. (the “Company”) for the quarter ended December 31, 2010, each of the undersigned Eugene Seymour, the Chief Executive Officer of the Company, and, the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigned’s knowledge and belief:
|
(1)
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Dated: February 18, 2011
|
/s/ Eugene Seymour
|
|
Name: Eugene Seymour
|
|
|
Title: Chief Executive Officer and Interim
Chief Financial Officer
|
|
|
(Principal Executive Officer and Principal Financial Officer)
|
|
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company as part of the Report or as a separate disclosure document for purposes of Section 18 or any other provision of the Securities Exchange Act of 1934, as amended.